Japanese researchers have used an advanced microspectroscopy
technique to study the cell cycle of yeast without the need for
fluorescent imaging agents that can potentially alter the cellular
A potential therapy, which specifically targets cancer cells, could
be in the offering after Neotropix received FDA approval to begin
clinical trials of a drug candidate that offers new drug treatment
hope for advanced cancers.
Pharmaceutical company, Phosphagenics, has announced the
commencement of animal studies on its anti-cancer compound, which
claims to destroy diseased cells while not affecting normal ones by
primarily acting as a signalling molecule...
The question as to why some cancers resist drugs could be answered
by the discovery of new mechanisms, which delve deeper into how
cancer cells evolve to become resistant to various chemotherapy
The possibilities nanotechnology has in drug and therapeutic
applications was demonstrated once again after researchers were
able to demonstrate the destruction of cancer cells whilst keeping
healthy tissue unharmed.
Scientists have created the nanotechnology equivalent of a Trojan
horse to smuggle a powerful chemotherapeutic drug inside tumour
cells - increasing the drug's cancer-killing activity and reducing
its toxic side effects.
Cytopia has received the green light to trial a promising new drug
that could prove effective in the fight against advanced solid
tumours. In animal studies, the drug candidate has already shown
efficacy in killing cancer cells in...
US researchers have developed a new approach to fighting cancer,
which uses nanoscale particles that can detect and destroy
cancerous cells. This ability differentiates it from current
molecular imaging approaches, which only detect...
With the absence of any truly effective drug treatment for brain
tumours, news of researchers working on innovative treatments for
one of the deadliest tumour types raises the possibility of
readdressing the current situation and...
Researchers have found a protein, which plays a significant role in
colorectal carcinoma. The protein blocks the ability of tumours to
activate a natural self-destruct mechanism that would clear the
cancer from the body.
Cyclacel researchers and collaborators have solved the 3-D atomic
structure of human Proliferating Cell Nuclear Antigen (PCNA), a
protein involved in cancer. The discovery should prove crucial in
designing and developing drugs that...
The first grants given in the UK for drug development in early
phase clinical experiments have been awarded to gene therapy trials
that may herald a breakthrough in intra-abdominal cancer which has
an average survival rate of less...
Researchers in the UK have devised a means of using bacteria as a
means of delivering proteins into tumour cells and killing them,
raising the hope that this could form the basis of a new treatment